2018 American Transplant Congress

Tuesday, June 5, 2018

5:18pm-5:30pm

Increasing the Donor Pool for Highly Sensitized Patients with Allele Specific Antibodies: Optimizing the Virtual Crossmatch (vXM)

A. Zhang,¹ Z. Zaky,² J. Africa,³ D. Good,¹ R. Bray,⁴ H. Gebel.⁴

Concurrent Session: Kidney Donor Selection / Management Issues - 2  •  Room 6E

5:18pm-5:30pm

Living Donor Liver Transplantation for Alcoholic Liver Disease: Data from the A2ALL Study

H. Braun, J. Dodge, J. Grab, S. Syed, G. Roll, C. Freise, J. Roberts, N. Ascher.

Concurrent Session: Liver: Living Donors and Partial Grafts  •  Room 608/609

5:18pm-5:30pm

Living Kidney Donation: Impact of Transplant Center Labor, Organization, and Resources

D. Moore,¹ M. Dietrich,¹ P. Buerhaus,² J. Rodrigue,³ A. Minnick.¹

Concurrent Session: Kidney Living Donation: Programmatic Issues  •  Room 6B

5:18pm-5:30pm

Long-Term Risk of Solid Organ De Novo Malignancies after Liver Transplantation: A French National Study on 11226 Patients

O. Seree, M. Altieri, J. Dumortier, GReF2.

Concurrent Session: Liver: Hepatocellular Carcinoma and Other Malignancies  •  Room 6C

5:18pm-5:30pm

OX40 Costimulation Prevents Induction of Foxp3⁺ Tregs through Upregulation of Novel Repressors of Foxp3 Gene Expression

X. Zhang,¹ X. Xiao,¹ P. Lan,¹ J. Li,¹ Y. Dou,¹ W. Chen,¹ N. Ishii,² S. Chen,¹ E. Taparowsky,³ X. Li.^1,4

Concurrent Session: New Approaches to Target Regulatory T Cells  •  Room 618/619/620

5:18pm-5:30pm

Racing to Activation: Using LEAN Principles to Effectively Manage Your Waitlist with Predicted Improved Outcomes

L. Curry, V. Rao, D. Cassidy, V. Rohan, D. Dubay, N. Pilch, S. Gray.

Concurrent Session: Quality Assurance Process Improvement  •  Room 2AB

5:18pm-5:30pm

RNA Expression Profiling of Renal Allografts in the Cynomolgus Monkey Identifies Tolerance

R. Smith,¹ M. Matsunami,³ B. Adam,² A. Rosales,¹ T. Oura,³ A. Cosimi,³ T. Kawai,³ M. Mengel,² R. Colvin.¹

Concurrent Session: Kidney Immunosuppression: General Considerations - 2  •  Room 6A

5:18pm-5:30pm

Superior Renal Function with CNI-Free Everolimus over Standard CNI-Based Regimen: 18 Months Data from the Randomized, Multi-Center MANDELA Trial in De Novo Heart Transplant Recipients

M. J. Barten,¹ S. W. Hirt,¹ J. Garbade,¹ C. Bara,¹ A. Doesch,¹ C. Knosalla,¹ C. Grinninger,¹ J. Stypmann,¹ C. Sieder,² M. Junge,² U. Schulz.¹

Concurrent Session: Late Breaking  •  Room 3AB

5:18pm-5:30pm

Transplant Community Perceptions of the Benefits and Drawbacks of Alternative Quality Metrics for Regulation

S. Rasmussen, S. Zhou, A. Thomas, D. Segev, L. Hersch Nicholas.

Concurrent Session: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics - 3  •  Room 4C-4

5:18pm-5:30pm

Unbiased Sequencing of Urine Cell-Free DNA (cfDNA) to Evaluation Urine Virome and Associated Renal Allograft Damage

D. Dadhania,¹ P. Burnham,² J. Lee,¹ C. Snopkowski,¹ C. Li,¹ S. Albakry,¹ H. Yang,¹ T. Muthukumar,¹ I. De Vlaminck,² M. Suthanthiran.¹

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes: Clinical  •  Room 602/603/604